HOUGEN ELIZABETH L
Director; EVP, Finance & CFO · 5 filings · Latest: Sep 10, 2026
Artiva Biotherapeutics, Inc.
IONIS PHARMACEUTICALS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
IONS | HOUGEN ELIZABETH L | EVP, Finance & CFO | Mar 17, 2026 | Sale | $73.21 | 10,172 | $744.7K | 82,660 | |
IONS | HOUGEN ELIZABETH L | EVP, Finance & CFO | Mar 16, 2026 | Sale | $72.40 | 215,048 | $15.6M | 92,832 | |
IONS | HOUGEN ELIZABETH L | EVP, Finance & CFO | Mar 16, 2026 | Option Exercise | $51.37 | 174,999 | $9.0M | 307,880 | |
IONS | HOUGEN ELIZABETH L | — | Mar 16, 2026 | Proposed Sale | $72.31 | 225,200 | $16.3M | — | |
IONS | HOUGEN ELIZABETH L | EVP, Finance & CFO | Jan 30, 2026 | Sale | $83.24 | 6,988 | $581.7K | 132,881 | |
IONS | HOUGEN ELIZABETH L | — | Jan 30, 2026 | Proposed Sale | $83.01 | 6,988 | $580.0K | — | |
IONS | HOUGEN ELIZABETH L | EVP, Finance & CFO | Jan 16, 2026 | Sale | $75.22 | 12,922 | $972.0K | 126,307 | |
IONS | HOUGEN ELIZABETH L | EVP, Finance & CFO | Jan 15, 2026 | Option Exercise | $0.00 | 28,729 | — | 139,229 | |
IONS | HOUGEN ELIZABETH L | — | Jan 16, 2026 | Proposed Sale | $76.24 | 12,922 | $985.1K | — | |
IONS | HOUGEN ELIZABETH L | — | Sep 30, 2025 | Proposed Sale | $65.26 | 49,800 | $3.2M | — | |
IONS | HOUGEN ELIZABETH L | — | Jan 31, 2025 | Proposed Sale | $35.00 | 2,069 | $72.4K | — | |
IONS | HOUGEN ELIZABETH L | — | Jan 16, 2025 | Proposed Sale | $32.70 | 8,870 | $290.0K | — | |
IONS | HOUGEN ELIZABETH L | — | Feb 2, 2024 | Proposed Sale | $49.54 | 2,162 | $107.1K | — | Sep 5 1:25 AM 144/A |